Cargando…

Reply: The classification of p53 immunohistochemical staining results and patient outcome in ovarian cancer

Detalles Bibliográficos
Autores principales:	de Graeff, P, Hall, J, Crijns, A P G, de Bock, G H, Paul, J, ten Hoor, K A, de Jong, S, Hollema, H, Bartlett, J M S, Brown, R, van der Zee, A G J
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2007
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2359950/ http://dx.doi.org/10.1038/sj.bjc.6603742

Ejemplares similares

Factors influencing p53 expression in ovarian cancer as a biomarker of clinical outcome in multicentre studies
por: de Graeff, P, et al.
Publicado: (2006)

The ErbB signalling pathway: protein expression and prognostic value in epithelial ovarian cancer
por: de Graeff, P, et al.
Publicado: (2008)

Modest effect of p53, EGFR and HER-2/neu on prognosis in epithelial ovarian cancer: a meta-analysis
por: de Graeff, P, et al.
Publicado: (2009)

Potential Target Antigens for a Universal Vaccine in Epithelial Ovarian Cancer
por: Vermeij, Renee, et al.
Publicado: (2010)

Nutlin-3 preferentially sensitises wild-type p53-expressing cancer cells to DR5-selective TRAIL over rhTRAIL
por: Meijer, A, et al.
Publicado: (2013)

The classification of p53 immunohistochemical staining results and patient outcome in ovarian cancer
por: Lassus, H, et al.
Publicado: (2007)

The role of ATM and 53BP1 as predictive markers in cervical cancer
por: Roossink, Frank, et al.
Publicado: (2012)

Microfluidics for rapid cytokeratin immunohistochemical staining in frozen sections
por: Brajkovic, Saska, et al.
Publicado: (2017)

Problems with p53 immunohistochemical staining: the effect of fixation and variation in the methods of evaluation.
por: Fisher, C. J., et al.
Publicado: (1994)

Ovarian cysts in women receiving tamoxifen for breast cancer
por: Mourits, M J E, et al.
Publicado: (1999)

p53 immunohistochemical analysis in breast cancer with four monoclonal antibodies: comparison of staining and PCR-SSCP results.
por: Jacquemier, J., et al.
Publicado: (1994)

Subtype classification of malignant lymphoma using immunohistochemical staining pattern
por: Hashimoto, Noriaki, et al.
Publicado: (2022)

Detecting p53 gene mutation of breast cancer and defining differences between silver staining PCR-SSCP and immunohistochemical staining.
por: Ryu, J. W., et al.
Publicado: (2000)

Identification of genes and pathways associated with cytotoxic T lymphocyte infiltration of serous ovarian cancer
por: Leffers, N, et al.
Publicado: (2010)

Ber-H2 (CD30) Immunohistochemical Staining of Human Fetal Tissues
por: Tamiolakis, D, et al.
Publicado: (2005)

In squamous cell carcinoma of the vulva, overexpression of p53 is a late event and neither p53 nor mdm2 expression is a useful marker to predict lymph node metastases
por: Emanuels, A G, et al.
Publicado: (1999)

Digital image analysis of Ki67 proliferation index in breast cancer using virtual dual staining on whole tissue sections: clinical validation and inter-platform agreement
por: Koopman, Timco, et al.
Publicado: (2018)

Rising serum values of beta-subunit human chorionic gonadotrophin (hCG) in patients with progressive vulvar carcinomas.
por: de Bruijn, H. W., et al.
Publicado: (1997)

Immunohistochemical staining of radixin and moesin in prostatic adenocarcinoma
por: Bartholow, Tanner L, et al.
Publicado: (2011)

Validation of automated positive cell and region detection of immunohistochemically stained laryngeal tumor tissue using digital image analysis
por: Smits, Hilde J.G., et al.
Publicado: (2023)

Immunohistochemical/Histochemical Double Staining Method in the Study of the Columnar Metaplasia of the Oesophagus
por: Cabibi, D., et al.
Publicado: (2014)

TP53 Staining in Tissue Samples of Chronic Lymphocytic Lymphoma Cases: An Immunohistochemical Survey of 51 Cases
por: Kulaç, İbrahim, et al.
Publicado: (2017)

Glutathione S-transferase activity and isoenzyme composition in benign ovarian tumours, untreated malignant ovarian tumours, and malignant ovarian tumours after platinum/cyclophosphamide chemotherapy.
por: van der Zee, A. G., et al.
Publicado: (1992)

Tamoxifen effects on subjective and psychosexual well-being, in a randomised breast cancer study comparing high-dose and standard-dose chemotherapy
por: Mourits, M J, et al.
Publicado: (2002)

Parametric mapping of immunohistochemically stained tissue sections; a method to quantify the colocalization of tumor markers
por: Rademakers, Saskia E., et al.
Publicado: (2011)

Quantification of Immunohistochemically Stained Cells in Skin Biopsies
por: Emmanuel, Thomas, et al.
Publicado: (2022)

CD34 and p53 Immunohistochemical Stains Differentiate Hypocellular Myelodysplastic Syndrome (hMDS) from Aplastic Anemia and a CD34 Immunohistochemical Stain Provides Useful Survival Information for hMDS
por: Cha, Choong-Hwan, et al.
Publicado: (2014)

Prognostic Value of Immunohistochemical Staining of p53, bcl-2, and Ki-67 in Small Cell Lung Cancer
por: Paik, Kwang Hyun, et al.
Publicado: (2006)

Evaluation of the Pathogenesis of Tumor Development from Endometriosis by Estrogen Receptor, P53 and Bcl-2 Immunohistochemical Staining
por: Esmaili, Haidarali, et al.
Publicado: (2016)

A Novel Image Cytometric Method for Quantitation of Immunohistochemical Staining of Cytoplasmic Antigens
por: Guillaud, M., et al.
Publicado: (1997)

DNA topoisomerase IIα and -β expression in human ovarian cancer
por: Withoff, S, et al.
Publicado: (1999)

Discovery of new methylation markers to improve screening for cervical intraepithelial neoplasia grade 2/3
por: Boers, A., et al.
Publicado: (2016)

Molecular and immunohistochemical analysis of P53 in phaeochromocytoma.
por: Dahia, P. L., et al.
Publicado: (1995)

Clinical Relevance of p53 Immunohistochemical Stain in the Differential Diagnosis Between Pediatric Aplastic Anemia and Refractory Cytopenia of Childhood
por: Park, Sang Hyuk, et al.
Publicado: (2016)

Does immunohistochemical staining of P53, Ki 67 and cyclin A accurately predict Wilms tumor recurrence and survival?
por: Atwa, Ahmed M, et al.
Publicado: (2022)

Quantitative Comparison of Immunohistochemical Staining Intensity in Tissues Fixed in Formalin and Histochoice
por: Vince, D. Geoffrey, et al.
Publicado: (1997)

Prompt identification of primary cutaneous nocardiosis with immunohistochemical staining
por: Ash, Mark M., et al.
Publicado: (2020)

Calretinin immunohistochemical staining in Hirschsprung’s disease: An institutional experience
por: Zemheri, Ebru, et al.
Publicado: (2021)

The usefulness of immunohistochemical staining of bile tracts in biliary atresia
por: Cielecka-Kuszyk, Joanna, et al.
Publicado: (2021)

Cytology of malignant pleural mesothelioma: Diagnostic criteria, WHO classification updates, and immunohistochemical staining markers diagnostic value
por: Shaker, Nada, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_9c1ri3mffhupqcmrjl07hv9i6i